Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience

Tomoro Hishiki, Akihiro Fujino, Toshihiko Watanabe, Kazunori Tahara, Michinobu Ohno, Yohei Yamada, Kotaro Tomonaga, Mai Kutsukake, Takuro Fujita, Naonori Kawakubo, Kimikazu Matsumoto, Chikako Kiyotani, Yoko Shioda, Osamu Miyazaki, Hiroshi Fuji, Takako Yoshioka, Yutaka Kanamori

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience'. Together they form a unique fingerprint.

Medicine & Life Sciences